Showing results (121-130 of 167) with videos related to
Sort By:
Pageof 17
Gynecologic Oncology|February 27, 2024
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancerFelicia Roncolato, Madeleine T King, Rachel L O'Connell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX StudyNiall C Tebbutt, Kate Wilson, Val J Gebski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET TrialSebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell CancerBhavna Oza, Tim Eisen, Eleni Frangou, et al.The Lancet. Oncology|September 5, 2020
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-inAnna K Nowak, W Joost Lesterhuis, Peey-Sei Kok, et al.JAMA Network Open|February 21, 2022
Effect of Cancer Pain Guideline Implementation on Pain Outcomes Among Adult Outpatients With Cancer-Related Pain: A Stepped Wedge Cluster Randomized TrialMelanie R Lovell, Jane L Phillips, Tim Luckett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2024
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III TrialPeter Grimison, Antony Mersiades, Adrienne Kirby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancerMartin R Stockler, Vernon J Harvey, Prudence A Francis, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2025
Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancerSharon H Nahm, Belinda E Kiely, Rachel L O'Connell, et al.Clinical Genitourinary Cancer|June 23, 2026
Pembrolizumab and Denosumab in Clear-Cell Renal-Cell CarcinomaCarole A Harris, Danka S Zebic, Michelle F Morris, et al.Pageof 17